ISTANBUL escrs

Visual outcome and ocular complications of triamecinolon acetonide –assisted anterior vitrectomy during complicated cataract surgery with vitreous loss.

Session Details

Session Title: Cataract 2
Session Date/Time: Saturday 21/02/2015 | 08:30-11:00
Paper Time: 08:36
Venue: Hall 1
First Author: : H.Behboudi IRAN
Co Author(s): :                  

Abstract Details

Purpose:

Purpose: the transparent vitreous body in the anterior chamber is not visible , thus intracameral triamecinolon acetonide is necessary to evaluation the result of Triamecinolon acetonide –assisted anterior vitrectomy during complicated Cataract surgery with vitreous loss is useful.

Setting:

Amir hospital in Iran, ophthalmic research centrer

Methods:

Methods: 23 patients had vitreous loss during cataract surgery in 2 years anterior vitrectomy performed carefully in this patients with injection of triamecinolon acetonide in anterior chamber evaluation of BCVA and post operation complications performed 2 years after surgery.

Results:

Result: the mean age of patients is 67 years.(55-79) .BCVA of patients was between 20/50 to 20/20. One patient had post operation CME .four patients had rising of IOP which treated with topical glaucoma medication.post operation uveitis observed in one patient .corneal edema was 2 weeks after surgery in five patients .R. D and Endophthalmitis did not observe in any patients.

Conclusions:

Conclusion: based on BCVA and there were no cases of residual vitreous strands in the anterior chamber and decrease post operative complications, Triamecinolon acetonide –assisted anterior vitrectomy during complicated Cataract surgery with vitreous loss was safe procedure.

Financial Disclosure:

NONE

Back to previous